Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Transl Psychiatry ; 5: e576, 2015 Jun 02.
Artigo em Inglês | MEDLINE | ID: mdl-26035060

RESUMO

Major depression and bipolar disorder are associated with decreased bone mineral density (BMD). Antidepressants such as imipramine (IMIP) and specific serotonin reuptake inhibitors (SSRIs) have been implicated in reduced BMD and/or fracture in older depressed patients. Moreover, anticonvulsants such as valproate (VAL) and carbamazepine (CBZ) are also known to increase fracture rates. Although BMD is a predictor of susceptibility to fracture, bone strength is a more sensitive predictor. We measured mechanical and geometrical properties of bone in 68 male Sprague Dawley rats on IMIP, fluoxetine (FLX), VAL, CBZ, CBZ vehicle and saline (SAL), given intraperitoneally daily for 8 weeks. Distinct regions were tested to failure by four-point bending, whereas load displacement was used to determine stiffness. The left femurs were scanned in a MicroCT system to calculate mid-diaphyseal moments of inertia. None of these parameters were affected by antidepressants. However, VAL resulted in a significant decrease in stiffness and a reduction in yield, and CBZ induced a decrease in stiffness. Only CBZ induced alterations in mechanical properties that were accompanied by significant geometrical changes. These data reveal that chronic antidepressant treatment does not reduce bone strength, in contrast to chronic anticonvulsant treatment. Thus, decreased BMD and increased fracture rates in older patients on antidepressants are more likely to represent factors intrinsic to depression that weaken bone rather than antidepressants per se. Patients with affective illness on anticonvulsants may be at particularly high risk for fracture, especially as they grow older, as bone strength falls progressively with age.


Assuntos
Anticonvulsivantes/farmacologia , Antidepressivos/farmacologia , Densidade Óssea/efeitos dos fármacos , Fêmur/efeitos dos fármacos , Animais , Osso e Ossos/diagnóstico por imagem , Osso e Ossos/efeitos dos fármacos , Osso e Ossos/fisiopatologia , Carbamazepina/farmacologia , Fêmur/diagnóstico por imagem , Fêmur/fisiopatologia , Fluoxetina/farmacologia , Imipramina/farmacologia , Masculino , Ratos , Ratos Sprague-Dawley , Ácido Valproico/farmacologia , Microtomografia por Raio-X
2.
J Biomech Eng ; 123(5): 425-31, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11601727

RESUMO

The antero-inferior capsule (AIC) is the primary restraint to antero-inferior glenohumeral dislocation. This study utilizes a biomechanical model to determine the total strain field of the AIC in a subluxed shoulder. Strains were calculated from two capsule states: a nominal strain state set by inflation and a strained state set by subluxation. Marker coordinates on the AIC were reconstructed from stereoradiographs and strain fields calculated. Peak strain on the glenoid side of the AIC was significantly greater than the humeral side and strain fields were highly variable. This study reports an accurate method for measuring planar strains in a three-dimensional membrane.


Assuntos
Luxação do Ombro/diagnóstico por imagem , Luxação do Ombro/fisiopatologia , Articulação do Ombro/diagnóstico por imagem , Articulação do Ombro/fisiopatologia , Adulto , Idoso , Fenômenos Biomecânicos , Engenharia Biomédica/instrumentação , Humanos , Técnicas In Vitro , Pessoa de Meia-Idade , Modelos Anatômicos , Modelos Biológicos , Interpretação de Imagem Radiográfica Assistida por Computador , Estresse Mecânico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA